Product Details
Product Name:
Pavinetant |
CAS No.:
941690-55-7 |
Purity:
99.60% |
Supply Ability:
10g |
Release date:
2024/11/20 |
Product Introduction
Bioactivity
Name | Pavinetant |
Description | Pavinetant (MLE-4901) is an orally available neurokinin-3 receptor (NK3R) antagonist used to improve menopausal symptoms. |
In vitro | Pavinetant (AZD2624) is an effective NK3 receptor antagonist with potent inhibitory activity on microsomal CYP3A4/5[1]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 80 mg/mL (87.04 mM), Sonication is recommended.
|
Keywords | AZD 4901 | AZD 2624 | Pavinetant | MLE4901 | AZD-4901 | AZD-2624 | MLE 4901 |
Inhibitors Related | Rolapitant | Ezlopitant | (R)-CJ 11974 | N-Acetyl-L-tryptophan | Netupitant | Aprepitant | Befetupitant | Vofopitant | Fosaprepitant dimeglumine | Maropitant |
Related Compound Libraries | Bioactive Compound Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:19117-92-1
$155.00 / 1mg
-
CAS:912999-49-6
$38.00 / 1mg
-
CAS:75706-12-6
$39.00 / 50mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |